This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Cancer; other and unspecified primary
  • /
  • Activity of trabectedin and the PARP inhibitor ruc...

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas.

Read time: 1 mins
Published:11th Apr 2017
Author: Laroche A, Chaire V, Le Loarer F, Algéo MP, Rey C, Tran K et al.
Availability: Free full text
Ref.:J Hematol Oncol. 2017;10(1):84.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest